Next Generation Partners

Healthcare and life sciences in Sweden

Cirio Advokatbyrå AB

Cirio Advokatbyrå AB houses a team which is noted for its ‘large and in-depth‘ knowledge of the life sciences sector. The group handles a wide variety of mandates involving market access, rights issuances of shares, and trade mark mandates concerning parallel imports. Practice head Per Hedman utilises his vast regulatory knowledge to advise international pharma, medtech and biotech companies and investment entities. Praised for her specialism in personal data protection which makes her ‘unique within the Swedish market‘, Hanna Tilus is known for advising on technology transfers, co-marketing issues, and R&D collaborations.

Practice head(s):

Per Hedman

Other key lawyers:

Odd Swarting; Hanna Tilus


‘This team blends strong, commercial legal work with a deep industry knowledge in life sciences. They are hard to match in this combination. The team is also very responsive on legal queries outside major engagements, meaning they act as a trusted and reliable adviser.’

‘Per Hedman is our most trusted legal adviser in Sweden. He gives actionable, practical advice without unnecessary complexity. He blends this with deep life sciences expertise, making him a seamless lawyer to work with. He is responsive and always available in a crisis!’

‘The Cirio team are solutions-oriented and deliver clear advice that is easy to implement in our internal routines and procedures.’

‘Hanna Tilus has a deep understanding of the intersection between data protection and pharma, which makes her unique within the Swedish market. In addition to her excellent legal knowledge and experience, Hanna shows genuine understanding of our business, has a pragmatic approach, and is a joy to work with.’

‘The team has vast experience in the life sciences space, and give great advice in different ways to structure a deal in most successful way.’

‘Cirio is unique in its large and in-depth sector knowledge. Key strengths include having executed many types of transactions with clients, strategic intuition, and capacity.

‘My main contact is Per Hedman. Per stands out for his vast life sciences expertise, availability, and superior customer support. This has collectively built a genuine trust – regardless of the question I bring, I will receive superior support quickly.

‘Highly professional and knowledgeable, good service.’

Key clients


10x Genomics



Boule Diagnostics

Hadean Ventures

Karolinska Development


Scandinavian Biopharma

Sprint Bioscience



Annexin Pharmaceutcials

AlzeCure Pharma

Nordberg Medical

Lamera Medical


Sprint Bioscience AB

Work highlights

  • Represented Takeda in a market access matter.
  • Advised Ipsen on its acquisition of Albireo Pharma Inc (including two Swedish subsidiaries).
  • Advised Boule Diagnostics AB on its rights issuance of shares through which the company raised approximately SEK150m.

Mannheimer Swartling

Mannheimer Swartling houses a ‘highly skilled‘ practice, which acts for a diverse client base of medical device manufacturers, domestic and global pharma companies, and innovation focused healthcare providers. The ‘superbCamilla Appelgren leads the team, and is well known for advising on a range of regulatory matters, including cases against national agencies concerning pricing and reimbursement, market access, and clinical trials. ‘Very wise adviserPeter Nilsson has notable knowledge surrounding trial subject data issues and research projects, having assisted numerous healthcare and pharma clients. Emmie Montgomery is particularly adept at advising clients on the processing of patient data, in addition to advertisement-related issues.

Practice head(s):

Camilla Appelgren

Other key lawyers:

Peter Nilsson; Emmie Montgomery


‘Camilla Appelgren possesses a deep understanding of her field, demonstrating quick thinking and offering well-balanced advice. We value her professionalism and personal touch.’

‘Top tier team with an extensive knowledge within the life science area.’

‘Mannheimer Swartling always puts together a tight team, ensuring the right expertise for the topic at hand. They have deep experience within Pharma/Life Sciences with broad competences. It has always been easy to work with Mannheimer on challenging and complex issues – and the team has offered expert advice in a timely fashion.’

‘Peter Nilsson is probably the best lawyer I have across the region. He is an expert, extremely competent, and always ready to go the extra mile to help the clients. He is passionate.’

‘Highly skilled professionals, who demonstrate good understanding of complex issues, including scientific evidence. Very strong collaboration with business stakeholders.’

‘Camilla Appelgren is a superb lawyer, with a wealth of experience, and is a real pleasure to deal with.’

‘Peter Nilsson, will surely be the next partner in line if this is what his heart desires. Very read up on new therapies, understands how modern drugs work, commercial challenges – very wise adviser!’

‘Biggest life sciences practice in Sweden. In-depth knowledge of the sector. Very client-oriented. High quality advice. Also very good for litigation in that sector.’

Key clients

Bristol-Myers Squibb


Swedish Orphan Biovitrum AB

AbbVie AB

Inceptua S.A.

Lipum AB

Capio AB

Capio S:t Görans Sjukhus AB

Camurus AB



Humana Assistans AB

Work highlights

  • Represented Humana Assistans AB in major administrative court proceedings to challenge and set aside a decision by the Swedish Health and Social Care Inspectorate to revoke Humana’s operating permit.
  • Assisting BMS and Celgene (a BMS group company) with regulatory, commercial, pricing and reimbursement, and compliance matters.
  • Advised Impilo on its acquisition of Decon Wheel AB and VaccinDirekt.


Rated by clients as being ‘in a league of its own‘, Setterwalls maintains its stellar reputation for handling the full spectrum of mandates for diagnostic companies, drug distributors, and medical device clients. The group exhibits broad expertise in M&A, licensing and supply agreements, and disputes concerning generics and biosimilars. Leading the practice out of the Malmö office, Per Lidman is known for his longstanding IP expertise, regularly acting for pharma and medtech clients in patent disputes. Martin Levinsohn maintains an IP and competition-focused practice, with his caseload including market exclusivity and marketing-related issues within life sciences. Regulatory specialist Helena Nilsson is well-versed in mandates involving clinical studies, and classification and distribution issues.

Practice head(s):

Per Lidman

Other key lawyers:

Helena Nilsson; Martin Levinsohn; Hanna Sonning; Lovisa Dahl Nelson; Richard Hammarvid


‘They have a broad team with knowledge about the pharmaceutical market in Sweden.’

‘Martin Levihnson has deep knowledge and understanding of the pharma sector in Sweden. He is analytical and very skilled in presenting a case.’

‘Setterwalls has the unique ability to provide a team where all individuals have special but still overlapping competences. Their internal cooperation is immaculate and everyone had very high work ethics and competence. Setterwalls are not comparable with the other firms, but are in a league of their own.’

‘Helena Nilsson has a strong profile with broad experience in the regulatory authority side, which has been hugely helpful to us in connection with several authority discussions, both in relation to the reimbursement agency and the medicines product agency.’

‘Setterwalls has been an excellent legal adviser in the healthcare and life sciences sector, providing top-tier advice on complex contractual issues.’

‘Very strong subject matter skills. Very knowledgeable team and very hard working and committed. Always delivered on time and went the extra mile to make sure that agreements were as optimal as possible both from a legal and commercial perspective.’

‘Richard Hammarvid was very knowledgeable with a strong contact network with other law firms.’

‘Hanna Sonning has a good interdisciplinary background with strong knowledge about the life science sector.’

Key clients

Abacus Medicine

Accord Healthcare

Apoteksgruppen i Borrby nr 1 AB

Barry Callebaut



Coala Life

Doktorse Nordic

EQL Pharma

Fresenius Kabi

Gnosco AB

Gutfeeling Labs

Index Pharmaceuticals

Isofol Medical AB

Move & Walk Sverige AB



Nordic Trading Group

Novo Nordisk




Sever Pharma Solutions


Work highlights

  • Representing Nordic Trading Group B.V. against the Medical Products Agency (MPA) in the Supreme Administrative Court against the MPA’s decision to prohibit online sales of cannabidiol products to consumers in Sweden.
  • Representing Sandoz in a patent dispute with Bayer concerning Bayer’s patent for a once-daily dosing regimen for the active ingredient rivaroxaban, which is a pharmaceutical used in the prevention and treatment of thromboembolism.
  • Representing Neuraxpharm, a Spanish supplier of generic medicines, in a patent dispute against Biogen concerning Biogen’s patent for a specific dose of the active ingredient dimethylfumarate, which is used in the treatment of MS.

Advokatfirman Vinge

Advokatfirman Vinge houses a ‘highly skilled‘ team which is well-known for its expertise in patent disputes concerning royalty agreements, patent assignments, and supplementary protection certificates (SPC). The group frequently assists global pharma and biotech companies, healthcare corporates and investment funds within the life sciences and consumer health sectors. The ‘exceptionalStojan Arnerstål leads the team, and maintains a transaction-focused practice, advising on a range of manufacturing, commercialisation and development agreements within the pharma space. Noted for the ‘unrivalled depth‘ of his knowledge, Håkan Borgenhäll is an IP specialist who has notable experience in handling contentious matters involving registered designs, marketing issues and trade marks.

Practice head(s):

Stojan Arnerstål

Other key lawyers:

Håkan Borgenhäll; Malin Malm Waerme; Lisa Hörnqvist


‘Stojan Arnerstål is an exceptional adviser for commercial agreements, providing real value through his pragmatic, business-oriented approach and quick turnarounds in our matters. Excellent management skills.’

‘Vinge’s practice provides broad coverage and in-depth knowledge of the sector. They have a solid group of lawyers who are very responsive with a commercial mindset.’

‘Stojan Arnerstål has excellent knowledge and experience of the healthcare and life sciences industry. He is very skilled in conveying legal advice on commercial and complex matters in a practical and engaging way across all areas of the industry.’

‘Great team. Highly skilled. Super court advocates. I have had superb successes with them.’

‘Håkan Borgenhäll has immense experience litigating IP in Sweden. Unrivalled depth of knowledge.’

‘Malin Malm Waerme is a younger partner. Creative, super in court, proactive.’

Key clients

Eli Lilly and Company

Bridgepoint Growth

Fidelio Capital

Recipharm AB

Atlas Antibodies AB

Tamro AB

Vimian Group AB

Corline Biomedical AB

Medivir AB

Xspray Pharma AB

Hansa Biopharma AB

Calliditas Therapeutics AB

Oncopeptides AB

BioGaia AB

Nanoform Finland Plc

Medicover AB

Järven Plast & Smide Aktiebolag

Cinclus Pharma

A3P Biomedical


Attgeno AB

Work highlights

  • Representing Latvia MGI Tech SIA, MGI Tech Hong Kong Co., Ltd. and MGI International Sales Co., Ltd in 12 patent disputes where the counterpart is Illumina, a US company.
  • Represented Hansa Biopharma in an arbitration related to a patent assignment and royalty agreement and the request for royalties from certain researchers. The matter included complex interpretation of patent assignment and licensing agreements, including interpretation of the scope of protection of multiple patents.
  • Represented Attgeno in connection with an appeal to the Swedish Information Practices Committee (NBL). The matter concerned whether a paid article published by the company in collaboration with a newspaper was to be considered permitted scientific information regarding a certain medical condition, or whether the article was to be considered as unlawful pre-launch advertising of a not-yet approved pharmaceutical.

Advokatfirman Delphi

The ‘experienced and skilled‘ team at Advokatfirman Delphi acts for numerous pharma, medtech, and healthcare companies with a strong focus on innovation. Primarily based in Stockholm, the group has experienced growth in its workload with regard to regulatory advice on medical devices, and healthcare compliance. Practice head Elisabeth Eklund maintains a life sciences regulatory and competition-focused practice, with her primary area of focus being pricing and reimbursement cases, and distribution issues. Malmö’s Micael Karlsson regularly assists clients with corporate social responsibility issues, IPOs, and licensing matters. Public procurement specialist Martin Bogg regularly advises on the interpretation of government contracts, and the execution of public procurements.

Practice head(s):

Elisabeth Eklund

Other key lawyers:

Martin Bogg; Agne Lindberg; Peter Nordberg; Micael Karlsson


‘Team representing the key areas of interest within the field.’

‘The team has an exceptional understanding of the specific business needs in the life sciences sector.’

‘High level of engagement and with strong customer focus. Deliver on time, very speedy and with very high quality. The experienced and skilled personnel give the customer a high level of confidence.’

‘Very professional, high level of competence, focused, and with very good understanding of the customer’s daily business.’

‘Elisabeth Eklund has a deep understanding of the regulatory aspects of the pharma market in Sweden.’

Key clients

Inera AB

Intuitive Surgical Sarl

Nordicinfu Care AB

Unilabs AB

Hamlet Pharma AB

Olink Holding AB

Mendus AB


Enorama Pharma AB

Medimi AB

ProstaLund AB

Simris Group AB

Pharmacosmos AB

Work highlights

  • Assisted Inera AB with IT-procurements with a maximum value of more than SEK2.7 bn, concerning Sweden’s main healthcare applications, such as, a website which provides information about illnesses, care and health from the regions providing healthcare in Sweden.
  • Advised Olink Holding AB on the $116m offering of American Depositary Shares (ADSs). Each ADS represents one share in the company and the ADSs in the offering consisted of both newly issued shares and existing shares sold by certain shareholders of the company.

Advokatfirman Cederquist KB

The group at Advokatfirman Cederquist KB handles the full spectrum of matters concerning ethical codes and contracts with regulatory authorities within the life sciences and healthcare sector. Malin Allard and Annika Blomqvist jointly head up the practice. Allard is known for her longstanding IP expertise, with technology licensing agreements, strategic IP rights protection, and infringement actions being her main areas of focus. Blomqvist leads the public procurement practice at the firm, advising on distribution agreements, collaboration agreements with healthcare professionals, and clinical study commercial contracts. Dispute resolution expert Elsa Arbrandt acts in international arbitrations and regulatory disputes concerning clinical trials, in addition to advising on internal investigations.

Practice head(s):

Malin Allard; Annika Blomqvist

Other key lawyers:

Elsa Arbrandt


‘A very high level of service mindedness. A genuine interest in our needs and our success.’

Key clients

S Ahlén Medical Nordic AB

Aktiv Ortopedteknik i Sverige AB

Orkla ASA

Work highlights

  • Representing If Skadeförsäkring AB in complex court proceedings before the Stockholm District Court regarding serial loss claims involving several insurance companies, emanating from a number of ongoing class actions in North America and Canada.
  • Advised Lithuanian pharmacy company Euroapotheca on its joint combination with the Finnish company Oriola.
  • Advising a client on its negotiations for a distribution agreement with a manufacturer.

Westerberg & Partners

Westerberg & Partners‘ practice frequently assists pharma clients with product launches within the Swedish market. In addition to the group’s extensive contentious IP capability, it also regularly advises on research and development agreements. ‘Excellent‘ patent litigator Jonas Löfgren leads the team with his deep regulatory expertise, with particular emphasis on market access, and pricing and reimbursement matters. Wendela Hårdemark is well-versed in contentious matters concerning license agreements. Ludvig Holm regularly acts in patent and trade mark disputes, while Jonas Westerberg is noted for his vast knowledge of IP litigation and arbitration.

Practice head(s):

Jonas Löfgren

Other key lawyers:

Wendela Hårdemark; Ludvig Holm; Jonas Westerberg; Siri Alvsing


‘Jonas Löfgren is very experienced, with great knowledge of the Swedish market. He is very responsive and provides constant great legal support and practical solutions.’

‘First rate service. Jonas Löfgren in particular is excellent.’

‘Jonas Löfgren has hard-edged experience and is practical on very technical issues.’

Key clients

Alnylam Pharmaceuticals



Dr Wolff Group

Karo Healthcare

Illumina, Inc

Work highlights

  • Acted for Illumina in a multitude of parallel patent proceedings regarding the infringement and validity of patents in the DNA sequencing field.
  • Advised Dr. Wolf Group on the market access in Sweden of its first medicinal product, Axhidrox.


The ‘outstandingMalin von Heideken leads the team at Hammarskiöld, which handles a vast range of issues for its varied client base of generics manufacturers, parallel traders and pharma companies. The practice is well versed in non-contentious matters, including the drafting and negotiation of license and R&D agreements. Von Heideken is noted for her broad experience in representing clients before the Swedish administrative courts in commercial cases against government agencies. Sofia Falkner has a great deal of regulatory expertise, with her primary areas of focus being the pharma and medtech sectors. Falkner also has deep knowledge of Swedish and EU competition law, advising on a number of cartel investigations and the management of internal investigations.

Practice head(s):

Malin von Heideken

Other key lawyers:

Sofia Falkner


‘Highly professional, flexible and able to work on a risk-based basis. Not wasting resources while providing excellent advice.’

‘Very knowledgeable within life sciences and related legal matters, high availability and short turnaround times.’

‘Malin von Heideken is an outstanding partner to work with. Very professional in all aspects and high level of availability.’

‘Malin von Heideken is a great leader and a brilliant communicator with good common sense and analytical skills.’

Key clients



Asker Group (OneMed)





EpiEndo Pharmaceuticals


Althea Group

Thermo Fisher Scientific


Work highlights

  • Advised Sigrid on its clinical programme on SiPore, including legal aspects in relation to clinical studies. Also negotiated clinical study agreements, clinical research organisation agreements, and related services agreements.
  • Acted for Orifarm in two Administrative Court cases against the Swedish Medical Products Agency. The team is currently advising Orifarm in relation to one of these cases, which has been appealed to the Supreme Administrative Court.
  • Advised Cellcolabs on regulatory issues in relation to marketing and clinical trials. The team has also advised Cellcolabs on the negotiation of a major license agreement.

Advokatfirman Lindahl KB

Advokatfirman Lindahl KB houses a group known for its ‘strong and deep‘ knowledge of the sector, regularly assisting start-ups and venture capital backed companies, in addition to international players in the pharma industry. Praised for his ‘excellent‘ industry knowledge, Hugo Norlén leads the Uppsala-based team with his longstanding expertise in strategic collaborations and technology transfers within the pharma, medtech and biotech spaces. Gunnar Mattsson is noted for his broad expertise in corporate and international contractual matters, acting for a number of public and private life sciences companies, while Mikael Smedeby regularly handles issues concerning M&A and licensing transactions.

Practice head(s):

Hugo Norlén

Other key lawyers:

Gunnar Mattsson; Mikael Smedeby


‘Really client centered – always there when you need them, and rallies to bring the best team together depending on the area of expertise needed in each case. Strong and deep knowledge in the field of life sciences, makes a difference to work with an industry expert compared to a generalist.’

‘Down to earth, committed to the client, fast, problem-solving approach. Hugo Norlén has excellent industry knowledge and is really service-minded. He’s also really good at bringing in other parts of the team, when other expertise is needed.’

‘Good background knowledge and understanding of our business model, and the dynamics of the pharma industry in general. Pragmatic approach with valuable sharing of creative ideas to overcome roadblocks in negotiations. Very committed team, responsive and available when needed.’

Key clients

Affibody AB

Philips AB, Personal Heath

BioArctic AB

Palette Life Sciences AB

ThermoFisher Scientific/Phadia AB

Q-linea AB

Orexo AB

Senzime AB

Egetis Therapeutics AB

Eurocine Vaccines AB

Nanologica AB

Ilya Pharma AB

Vitrolife AB

Redwood Pharma AB

AMRA Medical AB

Dilafor AB

Nanexa AB

Intrance Medical Systems Inc

NeoDynamics AB

Miris AB

Stardots AB

BioLamina AB

Navinci Diagnostics AB

Salipro Biotech AB

Work highlights

  • Advised Palette Life Sciences on Teleflex’s $650m acquisition of the company.
  • Advised Corline Biomedical on a license agreement with the California-based company Imperative Care, with a total deal value of SEK1bn (approx. $90m).
  • Advised Ziccum in connection with a fully funded evaluation agreement with an international biopharmaceutical corporation focused on mRNA technologies.

Magnusson Advokatbyrå

Possessing ‘undeniable‘ expertise, the team at Magnusson Sweden is known for its expansive experience in public procurement work, with particular emphasis placed on patient safety and workflows, in addition to advising on commercial matters relating to the public sector. ‘Great‘ practice head Morvarid Dorkhan Nilsson regularly assists clients with a broad range of mandates, including the negotiation and drafting of manufacturing agreements, internal ethical guidelines, and permittable modifications to public procurement contracts. Helena Rönqvist maintains an IP and marketing focused practice, handling numerous commercial and IT agreements, while Wille Steinert is noted for his expertise in supply chains and the implementation of international policies and regulatory requirements.

Practice head(s):

Morvarid Dorkhan Nilsson

Other key lawyers:

Helena Rönqvist; Wille Steinert


‘They demonstrate the exceptional ability to be highly responsive to our specific needs on every occasion. One of their standout qualities is their capacity to rapidly comprehend and grasp the nuances of our situations and challenges. Every interaction feels as though we are their top priority, a sentiment that instills a strong sense of trust and partnership.’

‘Their expertise in our domain is undeniable, providing us with the confidence that our concerns are always framed within the correct legal context. Compared to other firms, their hands-on approach and tailored solutions truly set them apart.’

‘The individuals at the firm, much like the team as a whole, exemplify a dedication to understanding our specific needs. Among them, Morvarid Dorkhan Nilsson truly shines. She consistently nails the bullseye in grasping our requirements and delivering the right outcomes. Their level of personal commitment and expertise, especially from standout figures like Morvarid, is what sets them apart and adds immense value to our collaboration.’

‘We appreciated the high range of service areas covered by the firm, and the fact that we could work with a legal specialist who was knowledgeable in our industry.’

‘We highly appreciated working with Morvarid Dorkhan Nilsson. We were particularly appreciative of the business-oriented and goal-oriented approach to our case.’

‘Morvarid Dorkhan Nilsson is a great lawyer and communicator who has extensive business knowledge.’

Key clients

Becton Dickinson AB

Sedana Medical AB

Mediq Sverige AB

MediRum AB

Sverek AB

Continuum AB

Work highlights

  • Advised a global medical technology company on the complete review, implementation and alignment of global guidelines, policies and standard operating procedures to all Swedish laws and ethical guidelines applicable to medtech and pharmaceutical companies, with particular focus on interactions between the industry and the healthcare sector.
  • Assisted a publicly listed client within the medtech and pharmaceuticals industries, with particular focus on inhaled sedation. The team assisted with drafting and negotiating the necessary contract manufacturing agreements to outsource manufacturing.
  • Advised an innovative client on patient support programs, with detailing, analysing and complying with the framework of laws, industry standards and ethical guidelines applicable when implementing a patient support program in Sweden and Denmark.


Noted by clients for its ‘precision and skills‘, the team at Roschier is known for handling a variety of matters for its varied client base of innovation focused digital healthcare and pharma companies. Erik Ficks heads up the practice, and has broad experience in advising on transactional matters, including share acquisitions, in addition to acting in patent infringement actions in the pharma space. Björn Johansson Heigis leads the firm’s data protection and digitalisation practice, and is well versed in handling GDPR-related issues concerning medical devices, and research and development matters.

Practice head(s):

Erik Ficks

Other key lawyers:

Björn Johansson Heigis; Elias Olsson


‘The precision and skills from the team have helped us countless times and in particular Erik Ficks, with his skills, and ability to execute according to our agreed strategy, have been key to our strategy.’

Key clients

Neurim Pharmaceuticals

Philip Morris International

Work highlights

  • Representing Philip Morris International in its SEK176.4bn public offer for all shares in Swedish Match.
  • Represented Neurim Pharmaceuticals in patent litigation against a producer of generics.

DLA Piper Sweden

DLA Piper Sweden leverages its international network to advise its broad client base on pricing and reimbursement issues. Practice head Fredrika Allard is noted for her specialism in regulation governing the marketing of pharmaceuticals and collaborations between health professionals within the pharma industry, while competition specialist Erik Brändt Öfverholm has deep knowledge of domestic merger control mandates. Jennie Nilsson leads the firm’s digital, data and cyber group, regularly handling GDPR management projects and issues concerning transparency obligations and intra-group data transfers between companies.

Practice head(s):

Fredrika Allard

Other key lawyers:

Erik Brändt Öfverholm; Jennie Nilsson


‘The local representatives in Sweden were very pleasant, competent, efficient and delivered all tasks in a timely manner and according to all specs.’

‘I, as team leader from the Nordics, must mention that Fredrika Allard is extremely professional and knowledgeable in the field of pharma. She was always available to discuss, always took the time to re-evaluate if needed and adjusted the work and final product to our specific needs. I couldn’t give enough high praise for a job well done so far.’

‘Knowledgeable and accessible.’

Key clients

Jazz Pharmaceuticals

Gilead Sciences Sweden AB


Ipsen Pharmaceuticals


Qbtech AB

Dynamic Code AB

Doctrin AB

HerCare Sweden AB


Läkemedelsindustriföreningen (Lif)


Kartos Therapeutics LLC

Syneos Health

ABC Labs

Karolinska Development

Imagine Care



e-Verifikation i Sverige AB

Work highlights

  • Advised a US-based biotech company on questions regarding the transfer of human biological samples under new biobank legislation.
  • Advised ITB-Med, a Swedish biopharmaceutical company developing specific immunomodulatory biologics for transplantation, autoimmunity, neurodegenerative diseases and gene therapy, on various data protection matters, including issues relating to clinical trials.
  • Advised a pharmaceuticals company on reimbursement and administrative procedural law issues in relation to a decision issued by the Swedish Dental and Pharmaceutical Benefits Agency.

TM & Partners

The ‘fantastic‘ team at TM & Partners handles the full gamut of work relating to employment, commercial transactions, and compliance issues. Practice co-head Fredrik Gustafsson is an IT specialist who advises on IT procurements and strategic outsourcing mandates, while co-head Anna Jerndorf is known for her employment expertise. Equity capital markets expert Johan Wigh handles a wide variety of transactional matters, including the offering of preference shares and M&A transactions.

Practice head(s):

Fredrik Gustafsson; Anna Jerndorf; Johan Wigh


‘TM has extensive and deep knowledge within our sector, which gives us excellent support.’

‘Johan Wigh delivers high-quality service in a very personal and professional way.’

‘Fantastic team.’

‘Johan Wigh shows true grit and stands by your side at all times.’

Key clients

Air Liquide Biogas Solution Europe


Coala-Life Group AB

Otsuka Pharma



Team Olivia Group

Vivesto AB

Work highlights

  • Advising Otsuka Pharma on various legal matters.
  • Acting as Swedish counsel to Veranex in connection with all Swedish law aspects of its acquisition of Devicia and Clarvin together with affiliated companies Kickfile, Lea Group and Limulus Bio.